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Summary 
Gene expression is a multistep process that involves transcription, translation and 
turnover of mRNAs and proteins. Although it is one of the most fundamental processes 
of life, the entire cascade has never been quantified on a genome-wide scale. Here, we 
simultaneously measured mRNA and protein abundance and turnover by parallel 
metabolic pulse labeling for more than 5,000 genes in mammalian cells. While mRNA 
and protein levels correlated better than previously thought, corresponding half-lives 
showed no correlation. Employing a quantitative model we obtain the first genome-scale 
prediction of synthesis rates of mRNAs and proteins. We find that the cellular abundance 
of proteins is predominantly controlled at the level of translation. Genes with similar 
combinations of mRNA and protein stabilities shared functional properties, suggesting 
that half-lives evolved under energetic and dynamic constraints. Quantitative information 
about all stages of gene expression obtained in this study provides a rich resource and 
helps understanding the underlying design principles. 
Gelöscht: different 
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Introduction 
The four fundamental cellular processes involved in gene expression are transcription, 
mRNA degradation, translation and protein degradation. It is now clear that each step of 
this cascade is controlled by gene-regulatory events1-3. While each individual process 
has been intensively studied4-7, little is known about how the combined effect of all 
regulatory events shapes gene expression. The fundamental question of how genomic 
information is processed at different levels to obtain a specific cellular proteome has 
therefore remained unanswered. Genome-wide quantitative data about the flux of 
information from genes to proteins is not available for any organism. 
 
Towards a quantitative description of gene expression numerous previous studies 
compared steady-state mRNA and protein levels and arrived at the conclusion that the 
correlation is poor8. However, the available data suffers from several limitations. First, 
most studies are limited to a few hundred genes, mainly due to the technical challenges 
involved in large scale protein identification and quantification. For example, the largest 
mammalian protein copy number dataset comprises only 512 genes 9. Second, protein 
levels measured in one experiment are typically compared to mRNA levels determined 
in a different experiment performed at a different time in a different lab, making it difficult 
to interpret why the correlation is low. Third, mRNA levels are measured using 
microarrays which are less accurate than recent mRNA sequencing methods 10. Fourth, 
many studies were performed in bacteria or yeast and thus do not represent regulatory 
mechanisms specific for higher eukaryotes. Finally, mRNA and protein levels result from 
coupled processes of synthesis and degradation. Therefore, analysis of mRNA and 
protein levels alone cannot provide sufficient information to understand gene expression 
comprehensively. mRNA and protein turnover can be measured with drugs to inhibit 
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transcription or translation 11, but this has severe side-effects. Studies based on artificial 
fusion proteins are also problematic since tagging can affect protein stability 12. 
 
To overcome these limitations we sought to quantify cellular mRNA and protein 
expression levels and turnover in parallel in a population of unperturbed mammalian 
cells. Pulse labeling with radioactive nucleosides or amino acids is regarded as the gold 
standard method to determine mRNA and protein half-lives 13. Recently, variants of this 
approach based on non-radioactive tracers have been established 14-16. In stable isotope 
labeling by amino acids in cell culture (SILAC) cells are cultivated in a medium 
containing heavy stable-isotope versions of essential amino acids 17. When non-labeled 
(i.e. light) cells are transferred to heavy SILAC growth medium, newly synthesized 
proteins incorporate the heavy label while pre-existing proteins remain in the light form. 
This strategy can be used to measure protein turnover 18 or relative changes in protein 
translation 19. Similarly, newly synthesized RNA can be labeled with the nucleoside 
analog 4-thiouridine (4sU). 4sU containing mRNA can be biotinylated and affinity 
purified. Comparing the newly synthesized and pre-existing fraction allows for global 
quantification of mRNA half-lives 16,20. 
 
Parallel pulse labeling of proteins and mRNAs 
We used parallel metabolic pulse labeling with amino acids and 4sU to simultaneously 
measure protein and mRNA turnover in a population of exponentially growing non-
synchronized mouse fibroblasts (Fig. 1 A). Protein samples were harvested at three time 
points and analyzed by liquid chromatography and online tandem mass spectrometry 
(LC-MS/MS) on a high performance instrument (LTQ-Orbitrap-Velos). We identified and 
quantified proteins with the MaxQuant software package 21. During five days of data 
acquisition we measured 1,471,375 fragment spectra that resulted in 229,985 peptide 
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identifications (84,924 unique peptide sequences, false discovery rate (FDR) < 1%, see 
Supplementary Methods on ´Processing of mass spectrometry data´). These peptides 
were assigned to 6,445 unique proteins (FDR < 1%). 5,279 of these proteins were 
quantified by at least three heavy to light (H/L) peptide ratios (Fig. 1 B). Tissue-specific 
amino acid precursor pools and recycling rates, a pervasive problem for in vivo pulse 
labeling experiments15,22, did not appreciably affect our results (Fig. S1). We also tested 
if protein synthesis rates are uniform over time. In case of constant incorporation rates 
the logarithm of H/L ratios should increase linearly with time (Fig. 1 C). 93 % showed 
excellent linear correlation indicated by a variability of the linear regression slope smaller 
than 1 % (two and three time point measurements, Fig. 1 D). 
Thus, our data does not seem to be affected by non-uniform incorporation rates or by 
recycling. Also, protein abundance did not influence H/L ratio measurements (Fig. S 2).  
In total, we obtained a confident set of 5,028 protein half-lives calculated from the slope 
of the regression line (see Supplementary Methods). Cycloheximide-chase experiments 
for selected proteins spanning a representative range of half-lives agreed well with half-
lives determined by pulsed labeling and mass spectrometry in all cases (Fig. 1 E).  
 
In parallel, we pulse labeled newly synthesized RNA for 2 h with 4sU. RNA samples 
were fractionated into the newly synthesized and pre-existing fractions. Both fractions 
and the total unfractionated RNA sample were analyzed by mRNA sequencing on an 
Illumina Genome Analyzer. In total, we obtained 80,709,361 sequencing reads in all 
three samples, 55,046,553 (68%) of which could be mapped to the mouse genome. In 
all three samples, transcripts were quantified based on the number of reads mapped on 
their exonic region divided by transcript length and the total number of reads obtained 10. 
We calculated mRNA half-lives based on the ratios of newly synthesized RNA/total RNA 
ratio and the preexisting RNA/total RNA using the previously published approach16. 
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Importantly, this procedure compensates for different RNA yields during the fractionation 
process. To assess the reproducibility of protein and mRNA half-lives we performed an 
independent biological replicate of the entire large-scale experiment (see below). 
 
Proteins were on average five times more stable (median half-live 46 h) than mRNAs (9 
h) and spanned a bigger dynamic range (Fig. 2 A). Since very long (> 200 h) and very 
short (<30 min) protein half-lives cannot be accurately quantified from our three time 
points the true dynamic range of protein stabilities may be even higher (see 
Supplementary Methods). Intriguingly, we found no correlation between protein and 
mRNA half-lives (Fig. 2 C, R2 = 0.02, Rs = 0.16, both at log-log scale). Thus, many stable 
proteins have unstable mRNAs and vice versa. 
 
Absolute cellular mRNA and protein copy numbers  
We calculated absolute cellular mRNA copy numbers based on the number of 
sequencing reads in the unfractionated sample in conjunction with information on cellular 
mRNA content 10. Absolute protein copy numbers were inferred from mass spec data 
23,24. To this end, we used the sum of peak intensities of all peptides matching to a 
specific protein. When divided by the number of theoretically observable peptides, this 
value provides an accurate proxy for protein levels (‘intensity-based absolute 
quantification’ or iBAQ, see Supplementary Methods). As for half-lives, reproducibility of 
protein and mRNA copy numbers was assessed by performing an independent 
biological replicate (see below).  
 
Levels of detected proteins spanned ~5 orders of magnitude (Fig. 2 B). Since relatively 
few proteins had less than 100 copies per cell we reasoned that some low abundant 
proteins escaped detection. Indeed, comparing mRNA levels of detected and not 
7 
 
detected proteins revealed a moderate detection bias (Fig. S3). We therefore restricted 
our analysis to the set of genes that were identified at both the mRNA and protein level. 
In this subset, proteins were on average ~900 times more abundant than their 
corresponding transcripts. Despite a huge spread mRNAs and protein levels were 
clearly correlated (Fig. 2 D, R2 = 0.41, Rs = 0.62, both at log-log scale). An attempt to 
further improve this correlation by non-linear transformation resulted only in a marginal 
increase (R2=0.44, Fig. S4). It appears that for our data set, this is about the maximum 
correlation between RNA and protein that can be achieved without making use of 
additional information. This correlation is considerably higher than in any previous study 
in mammals8,9. For example, the recent study by Vogel and co-workers found an R2 of 
0.29 for a set of 512 mostly abundant proteins.  
Our data therefore suggests that the often claimed poor correlation between mRNAs and 
proteins can partially be explained by non-parallel sample acquisition and/or imprecise 
measurements. Collectively, our data indicates that mRNA and protein levels correlate 
better than previously thought. 
 
Reproducibility 
To investigate the experimental noise we performed a second independent large-scale 
experiment and measured mRNA and protein levels and half-lives again. The overall 
correlation of half-lives and levels between both replicates was good (Fig. S5 and 
Supplementary Table 1 for more detailed error estimates).   
 
To test if experimental noise affects the observed correlation between mRNAs and 
proteins we successively discarded genes with the highest variability between both 
replicates. For the remaining fraction we investigated correlation of mRNA and protein 
levels again. Removing less consistent data points did not increase correlation between 
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mRNA and protein levels (Fig. 2 F). Similar results were obtained for half-lives (Fig. 2 E). 
Therefore, noise has little impact on the observed correlation between mRNA and 
protein levels and half-lives. 
 
To exclude systematic errors we sought to quantify absolute mRNA and protein copy 
numbers using independent methods. For mRNA copy numbers we employed the 
NanoString technology which captures and counts individual transcripts without 
enzymatic reactions or bias25. Correlation between Illumina sequencing and NanoString 
data was high (R = 0.79, see also Fig S6 A). Absolute protein quantification was 
validated by spike-in experiments using a mixture of 48 proteins with known 
concentrations (Fig. S6 B). iBAQ values correlated well with known absolute protein 
amounts over at least four orders of magnitude and had a higher precision and accuracy 
than alternative measures of absolute protein abundance (data not shown)23,24.   
 
A quantitative model of gene expression allows genome-wide prediction of 
transcription and translation rates 
Our data allows calculating average synthesis rates of mRNAs and proteins for 
thousands of genes employing a mathematical model (Fig. 3 A and Supplementary 
Methods). The experimental data is based on a population of non-synchronized cells. 
Therefore, our estimated rates provide an average over the population and time. They 
do not describe gene expression in single cells which requires single cell 
measurements26. 
 
Average cellular transcription rates predicted by the model spanned two orders of 
magnitude with a median of about two mRNA molecules per hour (Fig. 3 B). An extreme 
example was mdm2 with more than 500 mRNAs per hour, consistent with the 
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extrachromosomal amplification of this gene in NIH3T3 cells. Since this is the first 
genome-scale estimate of mammalian transcription rates we cannot compare it with 
existing data. A microscopic study on the cytomegalovirus (CMV) promoter reported 
transcription termination rates of 5.8 to 8.7 mRNAs per hour 27. These values are above 
the median of our predictions as perhaps expected for a rather strong promoter system.  
 
Next, we calculated translation rate constants, i.e. how many proteins are made from 
each mRNA template per hour (Fig. 3 C). We find a median translation rate constant of 
about 40 proteins per mRNA per hour. Several proteins involved in translational 
regulation such as the translation initiation factor eIF4G, fragile X syndrome related 
protein Fxr2 and Tuberin had extremely low rate constants, i.e. were translationally 
repressed. Plotting translation rate constants against protein levels revealed that 
abundant proteins are translated about 100 times more efficiently than low abundant 
ones (Fig. 3 D). Hence, different translation efficiencies seem to contribute to the higher 
dynamic range of proteins compared to mRNAs (Fig. 2 B). Intriguingly, translation rate 
constants saturated at around 180 protein copies / (mRNA*h). This is unlikely a signal 
saturation artifact since we did not observe dynamic range compression of protein levels 
(Fig. S6 B). Alternatively, the observation can be interpreted as a maximal translation 
rate constant. To our knowledge, the maximal translation rate constant in mammals is 
not known. Based on Davidson and co-workers the estimated maximal translation rate 
constant in sea urchin embryos is 140 copies / (mRNA*h) 1 which is surprisingly close to 
the prediction of our model for mouse fibroblasts. We also assessed degradation and 
synthesis rates for mRNAs and proteins by actinomycin D and cycloheximide treatment, 
respectively (Supplementary Methods). For high turnover proteins and mRNAs we 
obtained results consistent with pulse labeling data (Fig. S6 C-F).  
 
Gelöscht: estimated 
Gelöscht: in sea urchin 
embryos 
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Estimating the impact of post-transcriptional, translational and post-translational 
control on protein abundance 
A long standing question is how much protein abundance is controlled at the 
transcriptional, post-transcriptional, translational and post-translational level. Until now, 
this has mainly been addressed indirectly by analyzing mRNA and protein sequence 
features. For example, features related to translation initiation (e.g. Shine-Dalgarno, 
Kozak and 3’ UTR sequences), elongation (e.g. codon bias) and protein stability (e.g. 
degrons) have been analyzed and reported to partially correlate with protein/mRNA 
ratios in bacteria, yeast and mammals9,28. We also observed sequence features 
characteristic of mRNA and protein stability and found that mRNAs with long 3’ UTRs 
are on average less stable (Fig. S7). In addition, the density of AU-rich elements (AREs) 
and binding motifs of specific RNA-binding proteins (Pumilio2) correlated negatively with 
mRNA stability (Fig. S8). Moreover, we observed that intrinsically unstructured proteins 
tend to have shorter half-lives, and we identified amino acids overrepresented in 
unstable proteins (Fig. S9). 
  
Sequence features are at best indirect proxies for the regulatory mechanisms controlling 
protein abundance. How much efficiencies of different steps in the gene expression 
cascade contribute to variance of cellular protein copy numbers can only be revealed by 
direct parallel genome-scale measurements of mRNA and protein levels and half-lives 
which were not available previously. In our data the coefficient of determination (R2) 
between mRNA and protein copy numbers was 0.41 (Fig. 2). If we assume absence of 
technical and biological noise, this means that ~40% of the variance in protein levels are 
explained by different mRNA levels – considerably more than previously thought (Fig. 4 
A). Most of these 40% are due to different transcription rates while mRNA stability plays 
a smaller role. Considering translation rate constants dramatically boosts R2 to 0.95 and 
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thus the correlation to 95%. Although this is an over-fit (see below), the analysis shows 
that translation rate constants play the dominant role for control of protein levels. 
Unexpectedly, the impact of protein degradation is rather small.    
 
In the above analysis the same experimental data was used to calculate synthesis rates 
and to estimate their impact on protein levels. To avoid this over-fit and to assess 
reliability of the model predictions we performed the same analysis with data from the 
biological replicate experiment. In this replicate experiment the coefficient of 
determination between mRNA and protein levels was 0.37 (Fig. 4 B). We then used the 
model including the estimated parameters from the first experiment to predict protein 
levels from mRNA levels in the replicate data. Predicted protein levels agreed very well 
with measured protein levels (R2 = 0.85, Fig. 4 C). Therefore, the model explains ~85% 
of the variability in protein copy numbers in an independent experiment. The correlation 
is very similar to the direct comparison of protein levels in both experiments (R2 = 0.84, 
Fig. S5 D). We conclude that (i) technical and biological noise in our data is low and that 
(ii) the model faithfully predicts protein levels from mRNA levels in mouse fibroblasts. It 
also indicates that the estimated impact of transcription, mRNA stability, translation and 
protein stability on protein abundance is reproducible. In the replicate experiment mRNA 
levels and translation rate constants combined can explain 75% of the variability in 
protein levels. We also assessed how much of the efficiencies of the various steps in 
gene expression are retained in a different cell type and organism. To this end, we 
quantified mRNA and protein abundance in the human breast cancer cell line MCF7 by 
RNA-seq and mass spectrometry, respectively. 2,030 human genes from the MCF7 
dataset had orthologs in the mouse fibroblast data. We then used rates from the mouse 
fibroblast model to predict protein levels from mRNA levels in human breast cancer cells. 
In MCF7 cells, the model predicted ~60% of the variability in protein levels (Fig. 4 A). 
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Although the fraction explained by the model is smaller than in mouse fibroblasts, this 
indicates that translation and degradation rates are to some extent independent of the 
cell type and conserved between mouse and human. 
 
Genes with similar combinations of mRNA and protein half-lives share functional 
properties 
It is well-known that degradation of proteins is critically involved in many cellular 
processes including cell cycle progression, signal transduction and apoptosis 7. Similarly, 
mRNA stability is important for the temporal order of gene induction20,29,30. Genes may 
have evolved specific combinations of mRNA and protein half-lives under functional 
constraints20,29-31. We therefore asked if genes with specific combinations of mRNA and 
protein stability have distinct biological functions. We grouped genes according to their 
combinations of mRNA and protein half-lives and used gene ontology to find enriched 
biological processes (Fig. 5 A, see Supplementary Table 2 for a complete list of GO 
terms with Benjamini-Hochberg adjusted p-values). 
  
Genes with stable mRNAs and stable proteins were enriched in constitutive cellular 
processes like translation (i.e. ribosomal proteins), respiration and central metabolism 
(glycolysis, citric acid cycle). Hence, many ‘house-keeping’ genes tend to have stable 
mRNAs and proteins. In lower organisms, energy costs keep transcription and 
translation rates under selective pressure32. We therefore reasoned that energy 
constraints may explain why ‘housekeeping’ genes tend to have stable mRNAs and 
proteins. Based on the model, we calculated the theoretical energy required to maintain 
cellular mRNAs and protein levels by recycling from their building blocks (nucleotide 
monophosphates and amino acids, respectively) in terms of high energy phosphates. 
This scenario corresponds to non-dividing cells in which the overall amount of mRNAs 
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and proteins stays constant. Therefore, the metabolic cost of synthesizing amino acids 
and nucleotides is not considered. mRNA synthesis costs were calculated for primary 
transcripts (i.e. including introns). The calculation is a conservative estimate since the 
energy needed for splicing, folding, transport etc. is not known and therefore not 
included. We found that protein synthesis consumes more than 90% of the energy while 
less than 10% is needed for transcription. 80% of the energy for translation is required to 
synthesize 20% of all proteins. Hence, protein synthesis follows the Pareto principle 
(“80/20 rule”) with a small fraction of proteins consuming most of the energy. If gene 
expression was optimized under energetic constraints abundant proteins are expected to 
be more stable than less abundant ones. This was indeed the case (Fig. 5 B, p<10-15, 
Wilcoxon test). This is not necessarily expected since the overall contribution of protein 
stability to protein levels is very small (Fig. 4 A). Consistent with the energy constraint 
abundant proteins were also significantly shorter (Fig. 5 C). Shuffling protein half-lives 
and lengths markedly increased theoretical energy consumption (Fig. 5 D). Similar 
results are obtained for mRNAs but their impact on overall costs is small. Collectively, 
these observations are consistent with the idea that mammalian gene expression 
evolved under energy constraints. 
 
The subset of genes with unstable mRNAs and proteins was strongly enriched in 
transcription factors, signaling genes, chromatin modifying enzymes and genes with cell 
cycle-specific functions (Fig. 5 A). Thus, many regulatory genes have low mRNA and 
protein half-lives. Since mRNAs and proteins are information carriers, their degradation 
can be interpreted as a built-in timer which controls persistence of genetic information33. 
Transcription of genes with short mRNA and protein half-lives has therefore only a short-
term impact on the protein level. In this scenario it makes intuitive sense that many 
transcription factors, cell cycle genes and chromatin modifiers have short mRNA and 
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protein half-lives. However, it must be stressed that our data cannot provide information 
about individual cells or molecules and should only be interpreted at the cell population 
level. 
 
The group of genes with stable proteins but unstable mRNAs was strongly enriched in 
terms related to processing of mRNAs, tRNAs and non-coding RNAs. This shows that 
many mammalian RNA-binding proteins are stable while their encoding transcripts tend 
to be short-lived, as noted recently for yeast34. Since many RNA-binding proteins bind 
their own message35, this observation is indicative of a post-transcriptional negative 
feedback-loop for RNA-binding proteins. Consistently, we found that unstable mRNAs 
are enriched for binding motifs of RNA-binding proteins (Fig. S8). 
 
Finally, the subset of genes with stable mRNAs and unstable proteins was rich in 
extracellular proteins. This is expected, since secreted proteins have a short cellular 
half-life. Additionally, this group contains proteins involved in cellular homeostasis, 
defense response and proteolysis. For example, this set contains two ferritin proteins 
which are rapidly up-regulated in response to iron36. Interestingly, ferritins are text book 
examples of translationally regulated genes. Since translational regulation is not 
dependent on mRNA half-lives, genes with stable mRNAs can still be dynamically 
regulated as long as their protein half-lives are short. It is tempting to speculate that 
other homeostasis genes in this group are regulated at the level of translation.  
 
Discussion 
Although gene expression is one of the most fundamental processes in biology it has 
never been quantified comprehensively. While it is now clear that regulation occurs at 
multiple levels, the flow of information from genes to proteins has not yet been 
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investigated on a genome-wide scale2,6. Here, we used parallel metabolic pulse labeling, 
mass spectrometry and next generation sequencing to provide the first analysis of 
mRNA and protein levels and half-lives for thousands of genes. We also report the first 
estimate of average transcription and translation rate constants predicted from our data. 
Our work provides a first global overview of mammalian gene expression dynamics from 
beginning (transcription) to the end (protein degradation). We provide novel insights on 
the steps that control protein abundance and shed new light on the underlying design 
principles. In the future, additional methods like sequencing of nascent transcripts and 
ribosome profiling may further refine this picture37.  
  
We found that mRNA levels explain around 40% of the variability in protein levels. This 
fraction is higher than in any previous study on mammals and does not seem to be 
affected by technical noise (Fig. 2 F). In yeast, mRNA and protein levels show a much 
higher correlation with mRNA levels already explaining 73% (R2=0.73) of the variability 
in protein levels8,9,23. One reason may be that higher eukaryotes show a higher degree of 
translational and post-translational regulation. We found that in mouse fibroblasts 
translation efficiency is the single best predictor of protein levels. Hence, protein 
abundance seems to be predominantly regulated at the ribosome, highlighting the 
importance of translational control for gene expression5. Whether this observation is 
valid in other cell types is not known. A recent study on embryonic stem cells revealed 
that changes in protein levels are not accompanied by changes in corresponding 
mRNAs, although this study did not discern translational and post-translational control38. 
It is also not clear how much translation rate constants change under different 
conditions. In fact, our observation that the mouse model can to some degree predict 
levels of orthologous proteins in MCF7 cells suggests that translation efficiency is 
partially ‘hard-coded’ in the genome and not subject to change. 
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Compared to translational control, protein stability seems to play a minor role for cellular 
protein abundance in our system. This might be surprising since protein degradation is 
involved in regulation of many cellular processes such as cell cycle progression7. From 
the global perspective, the dominance of translational regulation makes sense given the 
high energy costs associated with protein synthesis. Interestingly, the study by Maier 
and co-workers on a model bacterium comes to similar conclusions (see accompanying 
submission by Maier et al., 2010). However, it should also be stressed that our dataset 
represents average values derived from a population of dividing, non-synchronized cells. 
At the single cell level, the role of protein degradation for protein abundance may be 
higher. Similarly, protein degradation may be more important upon perturbation.  
 
Gene expression may follow certain design principles for optimal evolutionary fitness. 
Intriguingly, we found that genes with certain combinations of mRNA and protein half-
lives share common functions, suggesting they evolved under similar constraints. One of 
these constraints may be energy efficiency32. Consistently, we observed that the 
theoretical energy needed for gene expression is much lower than random. A second 
constraint may be the ability of genes to respond quickly to a stimulus. We find that 
many transcription factors and genes with cell-cycle specific function have unstable 
mRNAs and proteins, predisposing them to rapid transcriptional and/or translational 
regulation. In addition, genes with stable mRNAs but unstable proteins can be regulated 
quickly at the level of translation. These observations are consistent with the idea that 
many fast responding genes have short protein and/or mRNA half-lives20,30,31,39. The 
global picture is that most mRNAs and especially proteins tend to be stable unless 
genes need to respond quickly to a stimulus. Due to the trade-off between dynamic 
regulation and energy efficiency this may be an optimal design. Another design principle 
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emerges from the striking observation that many mammalian RNA-binding proteins are 
stable but encoded by unstable transcripts, as also seen in yeast34. 
 
Finally, our data provides a rich resource for the scientific community that can be mined 
in many ways that are beyond the scope of this study. For example, we provide by far 
the largest dataset on protein copy numbers which contains valuable information for 
modeling of cellular processes and stoichiometry of protein complexes24. Half-lives of 
proteins and mRNAs can be used to search for properties of unstable mRNAs or 
proteins, and we provide a first analysis of characteristic sequence features (Fig. S7 and 
S8). Genome-scale quantitative data on absolute mRNA and protein levels and half-lives 
will certainly help to understand the complex relationships between thousands of genes 
and their products in biological systems. 
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Figure legends 
 
Fig. 1: Parallel quantification of mRNA and protein turnover and levels. (A) Mouse 
fibroblasts were pulse labeled with heavy amino acids (SILAC, left) and the nucleoside 
4-thiouridine (4sU, right). Protein and mRNA turnover was quantified by mass 
spectrometry and next generation sequencing, respectively. (B) Mass spectra of 
peptides from a high and low turnover protein reveal increasing heavy to light (H/L) 
ratios over time. (C) Protein half-lives were calculated from log H/L ratios at all three time 
points using linear regression. (D) Variability of linear regression slopes assessed by 
leave-one-out cross validation was small. (E) Comparison of protein half-lives measured 
by SILAC and traditional cycloheximide-chase experiments. 
 
Fig. 2: mRNA and protein levels and half-lives. Histograms of mRNA (blue) and 
protein (red) half-lives (A) and levels (B). Proteins were on average 5 times more stable 
and 900 times more abundant than mRNAs and spanned a higher dynamic range. While 
mRNA and protein levels correlated significantly, correlation of half-lives was virtually 
absent (C,D). Consecutive removal of genes with highest deviation between biological 
replicates did not significantly increase correlations of mRNA and protein half-lives (E) or 
levels (F). 
 
Fig. 3: Quantitative model of gene expression in growing cells (A) mRNAs are 
synthesized with the rate vsr  and degraded with a rate constant kdr. Proteins are 
translated and degraded with rate constants ksp and kdp, respectively. (B) Calculated 
mRNA transcription rates show a uniform distribution. (C) Calculated translation rate 
constants are not uniform. (D) Translation rates of abundant proteins saturate between 
approx 120 and 240 proteins/(mRNA*h). Red line shows the locally weighted fit 
(LOWESS). Dashed lines indicate 95% confidence intervals of the LOWESS maximum 
value calculated by bootstrapping. 
 
Fig. 4: Impact of regulation at different levels on protein abundance  
(A) According to the model, protein levels are best explained by translation rates, 
followed by transcription rates. mRNA and protein stability is less important (left bar). (B) 
In a second, independent biological experiment mRNA levels explained 37% of protein 
levels in NIH3T3 cells (middle bar in A). (C) Using the model to predict protein levels 
from measured mRNA levels boosts predictive power to 85% (middle bar in A). The 
Formatiert: Schriftart: Nicht
Fett
Formatiert: Schriftart: Nicht
Fett
Gelöscht: Most proteins 
showed an excellent fit. 
Gelöscht: abundance
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mouse fibroblast model can to some extent predict protein levels from mRNA levels of 
human orthologs in MCF7 cells (right bar in A). Error bars show 95% confidence 
intervals estimated by bootstrapping. 
 
Fig. 5: Functional characteristics of genes with different mRNA and protein half-
lives (A) Genes were grouped according to their combination of mRNA and protein half-
lives and analyzed for enriched gene ontology terms. A heat map of enrichment p-values 
reveals functional similarities of genes with similar combinations of half-lives. (B, C) 
Abundant proteins are significantly more stable and shorter than less abundant ones 
(p<10-15, Wilcoxon test). (D) Theoretical energy consumption of gene expression. 
Randomizing protein half-lives or lengths enhances energy costs. Error bars show 95% 
confidence intervals determined by multiple randomizations and bootstrapping.  
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